GBT
CRL icon

Grove Bank & Trust’s Charles River Laboratories CRL Stock Holding History

Grove Bank & Trust’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.85K Hold
17
– – ﹤0.01% 756
2026
Q1 		$2.93K Buy
17
+16
+1,600% +$2.97K ﹤0.01% 759
2025
Q4 		$199 Hold
1
– – ﹤0.01% 847
2025
Q3 		$156 Hold
1
– – ﹤0.01% 825
2025
Q2 		$152 Sell
1
-19
-95% -$2.53K ﹤0.01% 848
2025
Q1 		$3.01K Buy
20
+12
+150% +$2.01K ﹤0.01% 739
2024
Q4 		$1.48K Buy
8
+1
+14% +$193 ﹤0.01% 706
2024
Q3 		$1.38K Buy
+7
New +$1.46K ﹤0.01% 692
2022
Q1 		– Sell
-680
Closed -$256K – 231
2021
Q4 		$256K Hold
680
– – 0.05% 204
2021
Q3 		$281K Hold
680
– – 0.06% 194
2021
Q2 		$252K Buy
+680
New +$227K 0.05% 192
2018
Q1 		– Sell
-680
Closed -$74K – 230
2017
Q4 		$74K Hold
680
– – 0.03% 255
2017
Q3 		$73K Buy
680
+100
+17% +$10.3K 0.04% 257
2017
Q2 		$59K Buy
580
+90
+18% +$8.28K 0.04% 235
2017
Q1 		$44K Hold
490
– – 0.04% 227
2016
Q4 		$37K Buy
+490
New +$37.2K 0.03% 261

Other funds holding CRL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return

Grove Bank & Trust's CRL Position: Q2 2026 in Review

Grove Bank & Trust held its Charles River Laboratories (CRL) position steady in Q2 2026 at 17 shares worth $3.85K. The position accounts for ﹤0.01% of the portfolio, ranked #756.

Grove Bank & Trust first reported a position in CRL in Q4 2016 and has held it in 16 quarters since. The position peaked at $281K in Q3 2021. 563 funds tracked by Wall St. Rank hold CRL as of Q2 2026.

  • Grove Bank & Trust held 17 shares of Charles River Laboratories worth $3.85K as of Q2 2026.
  • Grove Bank & Trust left its Charles River Laboratories share count unchanged in Q2 2026.
  • Charles River Laboratories made up ﹤0.01% of Grove Bank & Trust's portfolio in Q2 2026, its #756 holding.
  • Grove Bank & Trust first reported a position in Charles River Laboratories in Q4 2016 and has held it in 16 quarters since.
  • Grove Bank & Trust's Charles River Laboratories position peaked at $281K in Q3 2021.
  • 563 funds tracked by Wall St. Rank held Charles River Laboratories as of Q2 2026.

Based on Grove Bank & Trust's 13F filing for Q2 2026, filed 7 Jul 2026.